That would be a game changer. But then, as we know from the GBM trial, the "pinpoint" delivery is the other, current, obstacle.
Time will tell what "delivery-method" will in the end succeed. IV, IT, delivery via an OV or radioactive material or what else already exists, over time they will find a way to either re-activate a persons' immune system or lending it a helping hand.
And that again could make CHM a winner if CDH 17 and CLTX succeed as the " working mechanism " which just needs a better way to reach its target.
A lot of IFs and WHENs, until turned into a YES, will CHM still exist?
GLTA
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.747M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $11.33K | 3.775M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 75 | 71644408 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 87927011 | 26 |
View Market Depth
| Last trade - 14.48pm 31/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |